Sight Sciences Inc. (SGHT)
Sight Sciences Statistics
Share Statistics
Sight Sciences has 51.33M shares outstanding. The number of shares has increased by 3.17% in one year.
Shares Outstanding | 51.33M |
Shares Change (YoY) | 3.17% |
Shares Change (QoQ) | 1.14% |
Owned by Institutions (%) | 44.91% |
Shares Floating | 28.48M |
Failed to Deliver (FTD) Shares | 521 |
FTD / Avg. Volume | 0.2% |
Short Selling Information
The latest short interest is 1.07M, so 2.11% of the outstanding shares have been sold short.
Short Interest | 1.07M |
Short % of Shares Out | 2.11% |
Short % of Float | 3.59% |
Short Ratio (days to cover) | 4.91 |
Valuation Ratios
The PE ratio is -3.54 and the forward PE ratio is -4.31. Sight Sciences's PEG ratio is 0.37.
PE Ratio | -3.54 |
Forward PE | -4.31 |
PS Ratio | 2.28 |
Forward PS | 1.3 |
PB Ratio | 2.09 |
P/FCF Ratio | -8.03 |
PEG Ratio | 0.37 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Sight Sciences.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.04, with a Debt / Equity ratio of 0.46.
Current Ratio | 9.04 |
Quick Ratio | 8.63 |
Debt / Equity | 0.46 |
Debt / EBITDA | -0.88 |
Debt / FCF | -1.78 |
Interest Coverage | -10.84 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $369.75K |
Profits Per Employee | $-238.46K |
Employee Count | 216 |
Asset Turnover | 0.56 |
Inventory Turnover | 1.83 |
Taxes
Income Tax | 236K |
Effective Tax Rate | -0.46% |
Stock Price Statistics
The stock price has increased by -59.86% in the last 52 weeks. The beta is 2.45, so Sight Sciences's price volatility has been higher than the market average.
Beta | 2.45 |
52-Week Price Change | -59.86% |
50-Day Moving Average | 2.69 |
200-Day Moving Average | 4.78 |
Relative Strength Index (RSI) | 37.11 |
Average Volume (20 Days) | 259.62K |
Income Statement
In the last 12 months, Sight Sciences had revenue of 79.87M and earned -51.51M in profits. Earnings per share was -1.03.
Revenue | 79.87M |
Gross Profit | 68.28M |
Operating Income | -50.53M |
Net Income | -51.51M |
EBITDA | -45.9M |
EBIT | -46.61M |
Earnings Per Share (EPS) | -1.03 |
Balance Sheet
The company has 120.36M in cash and 40.36M in debt, giving a net cash position of 80M.
Cash & Cash Equivalents | 120.36M |
Total Debt | 40.36M |
Net Cash | 80M |
Retained Earnings | -346.3M |
Total Assets | 142.84M |
Working Capital | 124.31M |
Cash Flow
In the last 12 months, operating cash flow was -22.35M and capital expenditures -385K, giving a free cash flow of -22.74M.
Operating Cash Flow | -22.35M |
Capital Expenditures | -385K |
Free Cash Flow | -22.74M |
FCF Per Share | -0.45 |
Margins
Gross margin is 85.5%, with operating and profit margins of -63.27% and -64.49%.
Gross Margin | 85.5% |
Operating Margin | -63.27% |
Pretax Margin | -64.2% |
Profit Margin | -64.49% |
EBITDA Margin | -57.47% |
EBIT Margin | -63.27% |
FCF Margin | -28.47% |
Dividends & Yields
SGHT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for SGHT is $3.75, which is 67.4% higher than the current price. The consensus rating is "Hold".
Price Target | $3.75 |
Price Target Difference | 67.4% |
Analyst Consensus | Hold |
Analyst Count | 7 |
Scores
Altman Z-Score | -1.62 |
Piotroski F-Score | 3 |